CD274 and non-small cell lung carcinoma: Although some studies reported immunohistochemical and genetic variables such as PD‐L1 expression26, 27 and TMB28 as predictors of the therapeutic effects of ICIs in NSCLC, the detection of these biomarkers can depend on whether sufficient tumor tissue is obtained and requires invasive procedures for sampling.25